Related Experiment Video
Updated: Aug 16, 2026

Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
Body mass index predicts ventricular repolarisation in obese children: differential effects across obesity levels
Metin Karayakalı1, Kayıhan Karaman1, Tuba Kasap2
1Department of Cardiology, Tokat Gaziosmanpaşa University, Tokat, Turkey.
Insights
Childhood obesity is linked to abnormal heart repolarisation, even before metabolic issues arise. A body mass index (BMI) threshold can help identify children at risk for these early cardiac changes.
Area of Science:
- Cardiology
- Pediatrics
- Biomedical Engineering
Background:
- Childhood obesity is linked to cardiac electrical remodelling.
- The specific relationship between body mass index (BMI) and ventricular repolarisation (VR) heterogeneity in paediatric obesity is not fully understood.
Purpose of the Study:
- To investigate the association between BMI and VR heterogeneity in obese children.
- To identify predictors and thresholds for abnormal repolarisation in paediatric obesity.
Main Methods:
- Prospective observational study of 184 children (8-17 years; 112 obese, 72 normal-weight).
- Electrocardiographic analysis included traditional (QT, QTc, JT) and novel VR parameters (Tp-e interval, Tp-e/QT, Tp-e/QTc ratios).
- Multiple linear regression and ROC analyses were used to identify predictors and thresholds.
Main Results:
- Obese children showed significantly prolonged Tp-e intervals and elevated Tp-e/QTcB ratios.
- BMI was an independent predictor of VR heterogeneity, irrespective of metabolic or structural cardiac factors.
- A BMI threshold of ≥ 23.1 kg/m² was identified for abnormal repolarisation (AUC = 0.682).
Conclusions:
- Childhood obesity is associated with ventricular repolarisation abnormalities, independent of metabolic dysfunction or structural cardiac changes.
- These repolarisation abnormalities appear early in obesity via distinct pathophysiological pathways.
- A defined BMI threshold aids in early risk stratification for intervention.
Background:
Childhood obesity is associated with cardiac electrical remodelling, yet the relationship between body mass index (BMI) and ventricular repolarisation (VR) heterogeneity remains incompletely characterised in paediatric obesity.
Methods:
This prospective observational comparative study enrolled 184 children (112 obese, 72 normal-weight; age 8-17 years). Electrocardiographic analysis included traditional (QT, QTc, JT) and novel VR parameters (Tp-e interval, Tp-e/QT, Tp-e/QTc ratios). Multiple linear regression and receiver operating characteristic (ROC) analyses identified independent predictors and clinically applicable thresholds.
Results:
Obese children demonstrated significantly prolonged Tp-e intervals (87.83 ± 12.35 vs. 80.10 ± 16.80 ms, p = 0.002) and elevated Tp-e/QTcB ratios (0.211 ± 0.028 vs. 0.192 ± 0.034, p < 0.001). BMI emerged as the independent predictor of VR heterogeneity (β = 0.308, p < 0.001), after adjustment for insulin resistance, metabolic parameters, and echocardiographic findings. Regression analyses revealed differences in the BMI-repolarisation relationship: strong associations in normal-weight children (β = 0.353, p = 0.003), disappearing in established obesity (β = -0.041, p = 0.699), and a significant BMI × group interaction was observed (β = -2.079, p = 0.001). ROC analysis identified BMI ≥ 23.1 kg/m2 as the optimal threshold for abnormal repolarisation (AUC = 0.682, sensitivity 76.1%, specificity 50.0%, p < 0.001).
Conclusion:
Childhood obesity is associated with VR abnormalities independently of metabolic dysfunction and structural cardiac changes. This study suggests that repolarisation abnormalities occur in the early stages of obesity and through different pathophysiological mechanisms. The defined BMI threshold provides a clinically applicable tool for early risk stratification, highlighting the critical importance of intervention before obesity becomes established.
Related Concept Videos
Obesity
Drug Dosing: Obese Patients
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion